Friday, September 18, 2026

Capacity Is Not Security: The Missing Capability Behind Pharmaceutical Self-Reliance

Capacity Is Not Security: The Missing Capability Behind Pharmaceutical Self-Reliance

A factory is visible. Dependence is often invisible. For decades, industrial policy has tended to measure strength through things that can easily be counted: factories established, investment committed, machines installed, tonnes of capacity created and jobs announced. Pharmaceuticals expose the weakness of this approach more clearly than most industries. A plant may exist on paper and machinery may be ready to operate, yet the country can remain vulnerable if the plant cannot obtain critical inputs, maintain quality, control costs, retain skilled people and sell its output competitively. Capacity tells us what might be produced. Security depends on what can be produced reliably when it is actually needed.

India’s pharmaceutical success created a new kind of vulnerability. The rise of the Indian pharmaceutical industry is one of the important industrial stories of the post-1970 period. Process chemistry capabilities, generic medicines, entrepreneurial manufacturing and a large domestic market helped India become an important global supplier. But success in finished formulations did not automatically create independence across the entire production chain. Over time, economics encouraged firms to source some bulk drugs, key starting materials and intermediates from highly competitive external suppliers. This was commercially rational for individual companies. At the level of the national economy, however, concentrated dependence created strategic risk. The lesson is uncomfortable but important: an industry can become globally successful at one stage of a value chain while simultaneously becoming vulnerable at another.

The new policy response is therefore necessary, but capacity should not be confused with the outcome. A Department of Pharmaceuticals release dated 27 March 2026 reported that 38 projects had been commissioned under the bulk-drug PLI scheme by December 2025, creating around 56,800 tonnes of annual capacity. It also highlighted support under PRIP for pharmaceutical research and stronger industry–academia linkages. These are meaningful programme milestones. But commissioned capacity does not tell us how much is being produced continuously, whether production is cost competitive, whether buyers are shifting from imports, whether plants can withstand price cycles, or whether strategically critical dependencies have actually fallen.

Tonnes may be the wrong unit for measuring security. Fifty thousand tonnes of relatively replaceable material may matter less strategically than a few hundred tonnes of an input without which an essential medicine cannot be manufactured. The future pharmaceutical-security map therefore cannot simply count aggregate domestic production. It must identify critical molecules, intermediates and starting materials; the number and geographical concentration of suppliers; switching possibilities; lead times; inventory requirements; quality constraints; and the consequences of disruption. Supply-chain security is ultimately about the importance of the missing component, not its weight.

The harder challenge begins after the factory is built. Pharmaceutical manufacturing is unforgiving. A producer must manage chemistry, process yields, energy, solvents, effluent treatment, analytical testing, equipment maintenance, documentation, regulatory compliance, working capital and customer qualification simultaneously. Failure in one area can undermine investment in all the others. This is particularly important for MSMEs. Smaller pharmaceutical companies may not need another subsidy as much as they need access to a process engineer, faster analytical testing, dependable utilities, affordable environmental services, regulatory expertise or patient working capital.

This is where cluster policy needs to change from building common facilities to solving common production problems. Before creating another testing centre, laboratory or common infrastructure facility, institutions should ask what is actually stopping enterprises from producing reliably. Is testing taking too long? Are specialised engineers unavailable? Is effluent treatment expensive? Are firms struggling with validation or documentation? Are utilities unreliable? Is process development weak? A shared facility without a clearly identified production bottleneck can become another building searching for users. The better cluster institution begins with the problem and only then decides whether the solution requires infrastructure, skills, technology, finance or coordination.

Biotechnology makes this distinction even sharper. Laboratories, incubators and research grants are useful, but buildings do not automatically produce innovation. Biotech capability develops when clearly defined technical problems meet capable scientific teams, patient capital, specialised equipment, intellectual-property strategy, regulatory pathways and firms capable of commercialisation. The distance between an experiment and a commercially viable product can be enormous. India therefore needs to measure not simply research expenditure or laboratories created, but how effectively knowledge moves from university to experiment, from experiment to validation, from validation to manufacturing and finally from manufacturing to the market.

The next stage of self-reliance must therefore be less dramatic and more demanding. The first generation of industrial policy asked whether India could manufacture something domestically. The next generation must ask whether India can manufacture it continuously, competitively and at the required quality without permanent protection. That means measuring plant utilisation, batch consistency, rejection rates, yields, delivery reliability, import displacement at the level of critical inputs, customer retention and the ability to survive normal movements in international prices.

Procurement and incentives can help companies cross the difficult early years. Strategic reserves may be justified for exceptionally critical materials. Public support can also help create markets where initial economics are difficult. But an industry that survives only while extraordinary support continues has created subsidised capacity rather than genuine resilience.

By the 2030s, pharmaceutical security may increasingly become a capability race rather than a capacity race. Countries will compete through process efficiency, advanced chemistry, biologics, continuous manufacturing, AI-assisted drug discovery, automation, regulatory credibility, traceable supply chains and the ability to move discoveries rapidly into commercial production. In such a world, simply possessing factories will become progressively less meaningful.

The real test of Atmanirbhar pharmaceutical manufacturing should therefore be surprisingly simple: Can the system keep supplying when conditions become difficult?

If production remains consistent, quality remains trusted, critical inputs remain available, customers continue buying and firms remain commercially viable, capacity has become capability.

That is when industrial capacity becomes industrial security.

#Pharma #Biotech #MSMEs #AtmanirbharBharat #SupplyChainResilience #Manufacturing #IndustrialPolicy


Thursday, September 17, 2026

​The Return of Stagflation Risk: When Inflation and Slow Growth Arrive Together

For much of the past forty years, economic policymaking became relatively comfortable. When growth weakened, central banks could reduce interest rates. When inflation increased, they could raise them. The problems appeared different and the medicines appeared reasonably clear. The world entering the late 2020s is becoming much less convenient. Inflation and weak growth can now arrive together, and geopolitics can produce both.

The ghost of the 1970s is returning in a different form. The word stagflation became part of economic vocabulary during the 1970s, when oil shocks demonstrated something uncomfortable. An economy could experience rising prices without experiencing strong demand or prosperity. Expensive energy raised the cost of transport, manufacturing, food and almost everything else while simultaneously reducing household purchasing power and industrial activity. Traditional demand-management policies struggled because reducing inflation could deepen the slowdown, while stimulating growth could intensify inflation.

The following decades gradually changed that environment. Globalisation expanded manufacturing capacity. China and other Asian economies supplied cheaper manufactured goods. International supply chains lowered production costs. Energy markets became more diversified. Independent central banks gained credibility. Inflation declined across much of the world.

The global economy began to believe that persistent stagflation belonged to economic history.

That assumption now looks increasingly fragile.

The new stagflation may begin outside the economy. The important change is the source of inflation. When inflation comes mainly from excessive domestic demand, interest rates can reduce spending and cool prices. But when inflation originates from disrupted oil supplies, expensive shipping, geopolitical conflict, trade restrictions, critical-mineral shortages or fragmented supply chains, monetary policy becomes a much weaker instrument.

A central bank can increase interest rates. It cannot produce oil.

It can reduce credit. It cannot reopen a shipping route.

It can suppress consumer demand. It cannot manufacture semiconductors, fertilizers, copper or rare earths.

This distinction may become one of the defining economic problems of the coming decade.

The IMF’s July 2026 outlook illustrates the tension. Global growth is projected at only 3.0 percent in 2026, below the 3.5 percent average recorded during 2024–25. At the same time, global headline inflation is projected to rise from 4.1 percent in 2025 to 4.7 percent in 2026. The IMF describes the earlier global disinflation process as having stalled, with higher energy and food prices playing an important role. (IMF eLibrary)

This is not necessarily a repeat of 1970s stagflation. But the combination deserves attention because the transmission mechanism is becoming familiar: an external supply shock raises prices while weakening real incomes and production.

Energy is no longer merely another commodity. It is becoming a macroeconomic transmission system. When energy prices rise sharply, the effect moves through almost every value chain. Fertilizer becomes more expensive. Food production costs increase. Transport becomes costlier. Chemicals, metals, plastics and textiles face higher processing costs. Electricity-intensive manufacturing loses competitiveness. Households spend more on fuel and utilities and therefore have less money for other consumption.

Inflation rises while demand can simultaneously weaken.

That is the stagflation mechanism.

The IMF’s July assessment also shows how uneven this process can be. Energy exporters outside conflict zones may benefit from better terms of trade, while energy-importing economies with limited participation in the technology boom can face considerably greater pressure. Meanwhile, countries strongly connected to the AI and technology investment cycle can receive an offsetting growth impulse. (IMF eLibrary)

This means the next stagflationary episode, if it develops, may not be globally uniform. It could produce a deeply divided world economy.

There may be three economies inside one global economy. Technology-intensive economies could continue investing rapidly in AI, semiconductors, data centres and advanced manufacturing. Energy-exporting countries could benefit from higher commodity revenues. But energy-dependent developing economies outside major technology value chains could face the worst combination: expensive imports, weaker currencies, high financing costs and slower growth.

The future development divide may therefore be determined not simply by income per capita but by three forms of strategic capacity: access to affordable energy, access to technology and the ability to finance shocks.

Countries weak in all three could become particularly vulnerable.

The central-bank dilemma is becoming structural. If inflation remains high, central banks may maintain or increase interest rates. But expensive money reduces housing demand, business investment and consumer spending. MSMEs are often hit particularly hard because they borrow at higher rates and possess smaller financial buffers.

If central banks instead reduce rates to protect growth, currencies may weaken and imported inflation may increase.

Neither choice attacks the original supply constraint.

This creates an uncomfortable possibility: monetary authorities may increasingly be asked to solve problems that monetary policy did not create and cannot directly repair.

The deeper solution therefore moves beyond interest rates.

Economic resilience may become the new inflation policy. Countries may need larger strategic energy reserves, diversified import sources, stronger electricity systems, renewable capacity, domestic food security, efficient logistics and alternative shipping arrangements. Firms may hold larger inventories, diversify suppliers and build redundancy into supply chains.

For decades, economics rewarded efficiency through minimum inventories, concentrated production and just-in-time supply systems. The emerging world may increasingly reward something different: the ability to continue operating when the cheapest supply route suddenly disappears.

That resilience will carry a cost. Redundant suppliers, inventories and domestic capacity can initially look inefficient. But the definition of efficiency changes when disruptions become frequent.

A factory supplied by the cheapest producer in the world is not necessarily competitive if geopolitical disruption repeatedly stops its production.

The future inflation battle may therefore be fought inside factories, ports and power systems as much as inside central banks. Energy productivity, renewable electricity, logistics efficiency, domestic supplier development, recycling, material substitution and technological upgrading could become instruments of macroeconomic stability.

This is especially important for developing economies. Countries that remain dependent on imported energy, imported technology and imported intermediate goods may repeatedly import inflation whenever geopolitics becomes unstable.

Industrial policy and inflation policy could therefore begin to overlap.

The larger danger is normalising expensive instability. One shock can be treated as temporary. Repeated shocks create a new economic structure. Wars, sanctions, shipping disruptions, tariff conflicts, climate events, mineral restrictions and supply-chain fragmentation can gradually raise the normal cost of doing business.

Then inflation does not require an overheated economy.

It can emerge from an overheated geopolitical system.

The world may consequently be entering an era in which policymakers cannot simply choose between fighting inflation and supporting growth. They may have to build economies capable of doing both simultaneously.

The defining economic question of the next decade may therefore not be whether stagflation returns in exactly the form experienced fifty years ago.

It may be whether our institutions are still designed for a world that no longer exists.

The old policy framework assumed that markets would remain globally connected, energy would remain accessible, supply chains would remain open and geopolitics would remain largely outside everyday economic management.

That assumption is disappearing.

The future may belong to economies that understand a simple but uncomfortable reality: price stability will increasingly depend on strategic resilience, and growth will increasingly depend on the capacity to survive disruption.


#Stagflation #GlobalEconomy #Inflation #Geopolitics #EnergySecurity #SupplyChains #EconomicPolicy



Wednesday, September 16, 2026

Beyond the Loom: The Capability Gap Behind Textile Investment

India may be entering a new phase of textile investment. New machines are being installed, new capacities are being planned and public incentives are encouraging firms to move into man-made fibres, technical textiles and higher-value products. But there is a danger in confusing investment with competitiveness. A textile machine can be purchased in a few months. The capability to satisfy a demanding international buyer may take years to build.

The history of textiles is really a history of accumulated capability. Successful textile centres were rarely created simply by putting factories in one location. Tirupur became important because knitting, dyeing, processing, garmenting, accessories, logistics, labour skills, exporters and buyers gradually grew around one another. Ludhiana developed its own ecosystem around hosiery, woollens, knitwear, machinery, traders and specialised skills. What appears today as manufacturing capacity is actually the result of decades of learning, relationships, experimentation and commercial trust.

This distinction matters because the next textile competition will be very different from the previous one. India is no longer competing only on the number of looms, spindles, knitting machines or sewing machines it possesses. It is increasingly competing on how quickly a firm can develop a new fabric, meet a performance specification, document compliance, reproduce quality consistently and deliver thousands of pieces exactly when promised.

Investment is becoming easier, but capability is still difficult. The Textile PLI programme illustrates this transition. By July 2026, 170 companies had been approved under the scheme. The October 2025 amendments reduced the minimum investment thresholds by 50 per cent, from ₹300 crore to ₹150 crore in one category and from ₹100 crore to ₹50 crore in the other, while also lowering the incremental turnover requirement and expanding eligible products. The government subsequently reported that 65 of the 96 applications received under Round 3 were from MSMEs. (Press Information Bureau⁠)

This is important. It means the investment door has become wider.

But walking through the door is not the same as reaching the market.

An approved investment tells us that a company intends to create capacity. It does not tell us whether an international sportswear company will approve its fabric, whether a technical textile will pass the required tests, whether colour consistency will survive repeated production runs, whether rejection rates will remain commercially acceptable or whether the buyer will return with another order.

That is the capability gap.

The factory is no longer the real competitive unit. The network is. A garment exporter may perform perfectly and still lose an order because the dyeing unit is inconsistent. A fabric producer may develop an excellent material but fail because testing takes too long. A technical textile manufacturer may install sophisticated equipment but struggle because specialised technicians are unavailable. An exporter may meet the price but lose the customer because an accessory supplier misses the delivery schedule.

This changes the economics of cluster development.

The old question was how much common infrastructure a cluster needed. The more useful question now is what market opportunity firms are unable to capture because a specific capability is missing.

That difference is fundamental.

A cluster does not necessarily need another building, laboratory or common facility centre. It may need faster access to an existing laboratory. It may need five highly trained technicians. It may need a product-development specialist who can work with twenty firms. It may need shared sampling capability. It may need certification support, digital traceability, chemical-management expertise or a mechanism connecting manufacturers with specialised international buyers.

Shared facilities should therefore begin with a buyer problem, not a construction plan. Before establishing a new facility in Tirupur, Ludhiana or another textile cluster, institutions should identify a product or buyer segment that local firms are repeatedly unable to enter. Then ask why.

Is the problem testing? Finishing? Product design? Certification? Small trial quantities? Skills? Machinery settings? Raw-material consistency? Buyer qualification?

Only after identifying the bottleneck should infrastructure be considered.

Every proposed shared facility should therefore have expected users, estimated trial volumes, trained technical staff, a realistic service price and a clear commercial problem that it solves. Where competent private capacity already exists, subsidising access, upgrading quality or building connections may produce better results than creating another institution.

The next industrial policy challenge is not capacity creation but capability creation. This distinction will become even more important as textiles move towards performance fabrics, recycled materials, smart textiles, medical applications, protective clothing, sportswear and increasingly traceable supply chains. Machines in these industries will become more sophisticated, but machines will also become globally available. Knowledge, organisational discipline, supplier coordination and trusted customer relationships will remain much harder to purchase.

This is where India’s textile policy may need its next evolution.

PLI has helped address the economics of investment and scale. The next layer should address the economics of experimentation. Small firms often hesitate to enter unfamiliar markets because the first experiment is expensive. Developing samples, testing materials, changing production settings, obtaining certification and approaching buyers all involve costs before there is any certainty of an order.

Clusters can reduce this risk collectively.

Shared product-development centres, specialised testing, demonstration production, technical mentoring, buyer-linked innovation programmes and pooled training can reduce the cost of experimentation without forcing firms to surrender their customers or confidential designs.

And this requires a different way of measuring success. Approved investment is easy to count. Installed machinery is visible. Buildings can be photographed. Capability is harder to measure.

But capability has its own evidence.

How many new samples were accepted by buyers? How many firms entered a higher-value product category? Did rejection rates fall? Did testing time decline? Did firms receive repeat orders? Did export margins improve? Did delivery become more reliable? Did MSMEs move from subcontracting towards direct customer relationships?

These indicators may tell us far more about competitiveness than the value of machinery installed.

The future textile race may ultimately be about who keeps the machines intelligently occupied. Countries can subsidise factories. Companies can import technology. Investors can finance production capacity. But markets cannot be ordered from a catalogue.

Demand has to be earned.

India therefore needs to look beyond the loom. The deeper textile infrastructure of the future will consist of skills, testing, product development, standards, information, specialised suppliers, logistics, buyer knowledge and commercial trust.

The loom produces fabric.

The ecosystem produces competitiveness.

And in the textile economy of the future, the countries and clusters that understand this difference may capture far more value than those that simply install more machines.

One particularly strong idea here is the shift from capacity creation to capability creation. Official figures show ₹8,117.64 crore of actual investment and 33,427 new jobs under the PLI scheme as of 31 March 2026, while the scheme’s 170 approved applicants collectively envisage much larger future investment, turnover and employment. That makes the distinction between approved/committed investment and demonstrated market capability especially 


#IndianTextiles #MSME #TextileIndustry #Exports #ClusterDevelopment



Tuesday, September 15, 2026

​The Missing Middle Between the Farm and the Food Brand

India can grow a crop, build a food factory and launch a brand, yet still struggle to connect the three profitably. The weakest point may be the ordinary journey between them. A small processor needs raw material of predictable quality, delivered at the right time, supported by working capital and a buyer who pays. When that chain breaks, a machine purchased with public support can become an expensive waiting room.

The shift beyond production. The historical success of raising agricultural output made availability a central policy concern. Processing adds a different challenge: turning seasonal and variable produce into a consistent product. A food enterprise competes through taste and price, but also through shelf life, packaging, delivery and trust. Abundant crops do not automatically produce dependable industrial inputs.

An April 2026 government backgrounder reported that processed food had increased its share of agricultural exports from 13.7 per cent in 2014–15 to 20.4 per cent in 2024–25. It also reported 34 lakh tonnes of additional annual processing and preservation capacity under the food-processing PLI scheme as of February 2026. These are dated indicators of a deeper processing economy. They do not establish how evenly the gains reached small processors or farmers. [Source 1]

The strategic interpretation is that the contest is moving towards organisation around the product. Large businesses can combine procurement, quality systems, brand recognition and distribution. A village enterprise cannot reproduce that entire structure on its own. Its disadvantage may have less to do with entrepreneurial effort than with the cost of buying each supporting service separately.

Build the connection before enlarging the factory. Consider a proposed fruit-processing cluster. Before expanding machinery, its institutions should establish whether growers can supply the required varieties and grades, whether collection is commercially viable, and whether buyers want the intended product. A shared laboratory is useful only if its results arrive in time and are accepted by customers. A cold store adds value only when the product, storage conditions and buyer schedule justify its operating cost.

For MSMEs, the practical priority is a small set of dependable services: aggregation, grading, appropriate storage, packaging support and buyer-linked production planning. Farmer organisations, processors and logistics providers need explicit responsibilities. Shared infrastructure without clear service standards risks transferring coordination problems into a new building.

The financial test should follow a batch from procurement to payment. How much is rejected? How long does inventory remain unsold? What proportion of deliveries leads to repeat orders? Do farmers receive a better net realisation after grading and transport costs? These questions reveal competitiveness more clearly than installed capacity alone.

The next food advantage. Digital records and better process control could help smaller firms qualify for demanding buyers. However, technology cannot repair an arrangement in which nobody accepts responsibility for quality failures or delayed payment. The durable opportunity lies in combining local agricultural knowledge with professional commercial services. A temporary price increase may attract investment; reliable supply and repeat demand must sustain it.

India’s food future will depend partly on who owns brands and factories. It will also depend on whether the enterprises between the farm and the final market can earn enough to keep the chain working.

good product. What connects them? Grading, storage, packaging, transp


Monday, September 14, 2026

​India’s Trade Policy Paradox: Faster Ports, Uncertain Promises

A factory can become more efficient and still become less competitive. Its workers may produce more, its machines may waste less, and its shipments may reach the port faster. Yet a change in input duties, a delayed certification or an unexpected restriction can wipe out those gains. For India, this is an uncomfortable possibility: public investment can accelerate the movement of goods while policy uncertainty slows the movement of business.

India’s eighth WTO Trade Policy Review, held on 21 and 23 July 2026, provides an opportunity to examine this tension. The exercise combines an independent Secretariat report, a government report and scrutiny by WTO members. It offers a detailed account of policy, but does not establish that a particular intervention caused productivity to rise or fall. The distinction matters when translating institutional findings into industrial strategy. (wto.org⁠)

From building industry to building reliability. After independence, India used protection and public investment to develop an industrial base in an economy short of capital and technological capacity. The reforms of 1991 widened the space for competition and international exchange. The next stage requires a harder achievement: making Indian enterprises dependable participants in production systems that cross borders repeatedly.

A manufacturer buying an imported component may be preparing an Indian export. A tariff that supports the component producer can raise costs for the enterprise using it. Both businesses belong to the domestic economy. Policy becomes misleading when it counts the gains of the protected industry without examining the losses of its customers.

The useful question is therefore how protection changes the capabilities of the entire production chain. Does it create better suppliers, stronger technology and competitive prices over time? Or does it allow one segment to charge more while another struggles to sell abroad?

Progress at the border, friction inside the system. The WTO reports that average import release times fell between 2023 and 2025 by approximately six hours at seaports and 18 hours at integrated check posts. It also places India’s average applied most-favoured-nation tariff at 15.7% in FY2025–26, including specified additional import levies. Participation in global value chains remains below the ASEAN average. These indicators show progress alongside continuing constraints; they do not establish a single cause for India’s competitiveness gap. (wto.org⁠)

For a small enterprise, however, the interaction is easy to understand. A faster port helps only after the business has identified the correct classification, confirmed the applicable requirements, arranged testing and secured its inputs. A smooth final stage cannot recover every delay accumulated earlier.

Consider a hypothetical exporter that agrees to a fixed price and delivery date. If an input requirement changes after the order is accepted, the firm may have to find another supplier, repeat testing or absorb additional costs. The overseas buyer experiences a broken promise, regardless of which institution caused the difficulty.

Predictability therefore has economic value. It allows firms to quote confidently, carry smaller precautionary inventories and commit money to expansion.

Quality must come with the capacity to comply. India’s government told the review that Quality Control Orders serve legitimate public policy objectives. Consumer safety and product reliability deserve serious protection. The question is how to achieve these objectives while enabling smaller producers to meet them. (pib.gov.in⁠)

A standard can raise quality when firms have access to suitable laboratories, technical advice, affordable testing and realistic transition periods. Where those conditions are missing, the same requirement can become a barrier that favours businesses with larger compliance departments.

This creates a difficult policy risk. A measure intended to improve products may also concentrate the market. That possibility requires investigation through evidence on testing costs, waiting times, supplier availability and business exits. Neither the announcement of a standard nor complaints against it settle the issue.

Before implementing major requirements, government should examine readiness in the clusters that must comply. Laboratory numbers alone are insufficient. What matters is whether the right test is available, recognised and affordable within the time a business can survive.

An incentive is a starting point, not a productivity result. Production-linked support should be judged by what enterprises can sustain after assistance ends. Additional output is useful, but the deeper questions concern domestic supplier development, worker skills, technological learning and competitiveness without continuing subsidy.

These outcomes require firm-level evidence. Supported enterprises may already have been positioned to expand. Demand may have risen independently. A credible assessment should distinguish production associated with a programme from production caused by it.

The same discipline should apply to import substitution. Replacing an imported product creates greater economic value when the domestic alternative becomes reliable and competitive. Counting the reduction in imports alone leaves the cost to downstream industries unanswered.

The next cluster institution must help firms understand the rules. Marketing assistance remains useful, but securing a buyer creates obligations that a cluster must be equipped to fulfil. Associations and common facility centres should develop shared services that explain regulatory changes, map product requirements, coordinate testing and identify risks to essential supplies.

Their value should be measured in practical outcomes: fewer rejected consignments, shorter certification delays, lower compliance costs and more repeat orders. A circular forwarded to hundreds of firms is not the same as a problem solved.

Major tariff and QCO changes should also undergo cluster-level impact assessments. These should examine which producers benefit, which input users bear costs, whether substitutes exist and how existing contracts will be affected. Emergency interventions may sometimes be necessary, but clear triggers and review dates can reduce avoidable uncertainty.

The future advantage is the ability to keep a promise. India’s industrial ambitions will depend on how well infrastructure, standards, trade rules and enterprise support work together. Each measure can appear reasonable on its own while their combined effect makes production harder.

The strongest trade policy will make it easier for a small manufacturer to improve quality, obtain inputs and deliver consistently. That is where national ambition meets everyday economic reality.

India can build more ports, factories and export platforms. Its next competitive advantage must also be built into the confidence with which an enterprise accepts an order—and keeps its promise.

#MSMEs #TradePolicy #ClusterDevelopment


Capacity Is Not Security: The Missing Capability Behind Pharmaceutical Self-Reliance

​ Capacity Is Not Security: The Missing Capability Behind Pharmaceutical Self-Reliance A factory is visible. Dependence is often invisible....